Chimerix, Inc. Elects Rodman L. Drake to Board of Directors

Published: Aug 02, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DURHAM, N.C., Aug. 2, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the election of Rodman L. Drake to the company's Board of Directors. He will serve as the Chairman of the Compensation Committee.

Help employers find you! Check out all the jobs and post your resume.

Back to news